The outlook of companies tied to the drug's legacy presents a intricate investment picture . While the initial boom generated substantial profits , generic alternatives have significantly eroded market share https://bookmarkingquest.com/story21553733/the-copyright-and-the-pharmaceutical-sector-a-uncertain-opportunity